The symptoms of pancreatic cancer can be nonspecific, which means identifying the disease is often a challenge.
Pancreatic cancer, one of the most aggressive and lethal types of cancer, continues to present significant challenges in both ...
Researchers randomized patients with advanced neuroendocrine tumors 2:1 to receive either cabozantinib or placebo.
Most patients with extrapancreatic neuroendocrine tumors or pancreatic neuroendocrine tumors eventually have disease progression with available therapies, and new treatments are needed.
New Blood Test Identifies Hard-to-Detect Pancreatic Cancer With 85% Accuracy Feb. 12, 2025 — A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival ...
Dr. Boris Naraev, a medical oncologist specializing in patient care for those suffering from gastrointestinal, neuroendocrine and endocrine tumors, has joined Tampa General Hospital’s (TGH) Cancer ...
Pancreatic cancer (PC) is the worst prognosis cancer globally, with just 13% of patients who are diagnosed with PC surviving ...
The National Medical Commission (NMC) has issued Guidelines for the competency-based postgraduate training programme for MCh ...
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback